Kascaid
4 employees on LinkedIn · 4 known investors
Find your way into Kascaid
Sign up to see every warm intro you have to Kascaid
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Kascaid team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Kascaid develops immune-monitoring technology that samples interstitial fluid instead of blood to capture more stable, cell-free molecular signals of immune activity. Its diagnostic platform targets applications in drug development and patient care.
Founders & leadership
SF

Scott FergusonCo-Founder & Chief Scientific OfficerScott Ferguson spent over a decade working in extracellular-vesicle biology, liquid-biopsy diagnostics, and translational assay development before co-founding Kascaid, where he leads scientific development of immune-monitoring technology.
Investors · 4
2048 Ventureslisted by 2048 VenturesNew York · $500K – $3M
How we know: 2048 Ventures's portfolio page · the VCSheet dataset · Not right? Tell us
Fifty Yearslisted by Fifty YearsSan Francisco · $250K – $2M
How we know: Fifty Years's portfolio page · Not right? Tell us
Spacecadet Ventureslisted by Spacecadet VenturesKent County · $100K – $500K
How we know: the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Kascaid do?
- Kascaid develops immune-monitoring technology that samples interstitial fluid instead of blood to capture more stable, cell-free molecular signals of immune activity. Its diagnostic platform targets applications in drug development and patient care.
- Who founded Kascaid?
- Kascaid was founded by Kavya Swaminathan, Austin B. Hall, Scott Ferguson.
- Who are Kascaid's investors?
- Kascaid's investors include 2048 Ventures, Draper Associates, Fifty Years, Spacecadet Ventures.




